查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1824612

2025年軟骨成形術全球市場報告

Chondroplasty Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年軟骨成形術市場規模將強勁成長，到2029年將達到184.4億美元，複合年成長率為6.0%。預測期內的成長可歸因於再生醫學的整合、對門診手術的關注、新型生物材料的引入、肌肉骨骼疾病的增加以及老年人口的成長。預測期內的主要趨勢包括復健技術整合、關節鏡技術、軟骨修復與再生、手術器械的創新以及導航系統的整合。

未來五年6.0%的成長率預測較先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國整形外科手術的發展，因為這會增加來自以色列和奧地利的射頻探頭和關節鏡軟骨修復工具的成本，減少關節保留手術的選擇，並增加運動醫學手術的成本。互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響也可能產生更廣泛的影響。

預計關節相關疾病的激增將成為推動軟骨成形術市場短期擴張的催化劑。這些疾病涵蓋多種影響關節功能的健康問題，通常由關節過度使用或突發性損傷（例如意外或運動相關事件）引起。軟骨成形術透過修復關節內受損的軟骨，可以治療這些關節相關疾病。 《柳葉刀》雜誌於2023年8月發布的最新數據顯示，英國痛風（一種影響關節的發炎性關節炎）的發生率正在上升。診斷率從2021年3月的每千名成年人1.40例上升至2022年3月的每千名成年人1.44例。此外，美國疾病管制與預防中心（CDC）2023年6月的預測估計，到2040年，約有7,840萬人（25.9%）18歲及以上美國成年人將經醫生診斷為關節炎（BRFSS）。因此，關節相關疾病盛行率的上升正在推動軟骨成形術市場的成長軌跡。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球軟骨成形術：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球軟骨成形術市場：成長率分析
  • 全球軟骨成形術市場表現：規模與成長，2019-2024
  • 全球軟骨成形術市場預測：2024-2029年、2034年規模與成長
  • 全球軟骨成形術：總潛在市場（TAM）

第6章 市場細分

  • 全球軟骨成形術市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 射頻消融術成形術
  • 磨損軟骨成形術
  • 髕骨軟骨成形術
  • 半月軟骨修復
  • 組織切除
  • 其他
  • 全球軟骨成形術市場（依解剖、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 膝蓋
  • 肩膀
  • 腰部
  • 其他
  • 全球軟骨成形術市場：按設備、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 刮鬍刀
  • 射頻設備
  • 關節鏡
  • 其他
  • 全球軟骨成形術市場最終用途、績效及預測（2019-2024、2024-2029、2034）
  • 醫院
  • 整形外科診所
  • 學術研究
  • 其他
  • 全球軟骨成形術市場：射頻消融術軟骨成形術細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 射頻消融術
  • 低頻消融
  • 全球軟骨成形術市場：燒蝕性軟骨成形術細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 機械磨損
  • 關節鏡擦傷
  • 全球軟骨成形術市場：髕骨軟骨成形術細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 開放式膝蓋骨軟骨成形術
  • 關節鏡膝蓋骨成形術
  • 全球軟骨成形術市場：半月軟骨修復細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 縫合技術
  • 半月軟骨
  • 全球軟骨成形術市場：組織去除細分、類型、績效及預測（2019-2024、2024-2029、2034）
  • 關節鏡創術
  • 開放清創術
  • 全球軟骨成形術市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 微骨折技術
  • 自體軟骨移植術

第7章 區域和國家分析

  • 全球軟骨成形術市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球軟骨成形術市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 軟骨成形術市場：競爭格局
  • 軟骨成形術市場：公司簡介
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Osiris Therapeutics Inc.
    • Thermo Fisher Scientific Inc.
    • Takeda Pharmaceutical Company Limited

第31章：其他領先和創新企業

  • Medtronic Public Limited Company
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings Inc.
  • Smith & Nephew plc
  • Sigma-Aldrich Corporation
  • Arthrex Inc.
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • CONMED Corporation
  • Promega Corporation
  • Organogenesis Holdings Inc.
  • Bioventus LLC
  • RTI Surgical Holdings Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年軟骨成形術市場：提供新機會的國家
  • 2029年軟骨成形術市場：細分領域帶來新機會
  • 2029年軟骨成形術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27660u

Chondroplasty is a surgical procedure designed to repair and reshape damaged cartilage within a joint, commonly performed to alleviate pain and improve joint function in cases of cartilage damage caused by conditions such as osteoarthritis or traumatic injuries.

The main types of chondroplasty include radiofrequency ablation chondroplasty, abrasion chondroplasty, patellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty targets minor imperfections in knee cartilage to minimize joint deterioration. Various anatomies, such as knee, shoulder, hip, and others, are addressed using tools such as shavers, radiofrequency devices, and arthroscopes. Chondroplasty procedures are performed in settings such as hospitals, orthopedic clinics, academic research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The chondroplasty market research report is one of a series of new reports from The Business Research Company that provides chondroplasty market statistics, including chondroplasty industry global market size, regional shares, competitors with a chondroplasty market share, detailed chondroplasty market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. This chondroplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chondroplasty market size has grown strongly in recent years. It will grow from $13.77 billion in 2024 to $14.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders.

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $18.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems.

The forecast of 6.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. orthopedic surgery by increasing the cost of radiofrequency probes and arthroscopic cartilage repair tools sourced from Israel and Austria, thereby reducing joint preservation options and elevating sports medicine procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in joint-related disorders stands as a catalyst propelling the expansion of the chondroplasty market in the foreseeable future. These disorders encompass a range of health issues affecting joint functionality, often stemming from excessive joint use or abrupt injuries, such as accidents or sports-related incidents. Chondroplasty serves as a treatment for these joint-related disorders by addressing damaged cartilage within a joint. Recent data published by The Lancet in August 2023 highlighted a rise in the incidence of gout, an inflammatory arthritis impacting joints, in the UK. The diagnoses increased from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. Furthermore, projections from the Centers for Disease Control and Prevention (CDC) in June 2023 estimate that by 2040, approximately 78.4 million (25.9%) US adults aged 18 years or older may receive doctor-diagnosed arthritis (BRFSS). Hence, the escalating prevalence of joint-related disorders is a driving force behind the chondroplasty market's growth trajectory.

The upswing in knee surgeries is poised to fuel the advancement of the chondroplasty market in the forthcoming period. Knee surgery denotes a surgical intervention targeting the knee joint to address a spectrum of conditions, injuries, or disorders impacting knee functionality. Chondroplasty, a surgical procedure focused on repairing and reshaping damaged cartilage within a joint, finds particular application in knee-related treatments. Notably, data from the National Library of Medicine revealed a substantial 18.3% increase in total hip and knee operations performed at over 1150 facilities in 2022 compared to 2020, totaling 2.4 million procedures. Moreover, projections from the same source in January 2023 indicate a projected surge of 139% in total knee arthroplasty (TKA) by 2040 and a striking 469% surge by 2060. As knee surgeries increase, the demand for chondroplasty is correspondingly boosted, fostering the growth dynamics of the chondroplasty market.

Leading companies in the chondroplasty market are advancing the development of autologous chondrocyte-based therapies to improve cartilage repair by leveraging patients' own cells, thereby minimizing immune rejection and encouraging natural regeneration. Autologous chondrocytes, which are cartilage cells harvested from a patient's body (typically from a non-weight-bearing area of the joint), provide a personalized approach to treatment. For example, in August 2024, Vericel Corporation, a U.S.-based biopharmaceutical company, gained FDA approval for its MACI Arthro (Matrix Autologous Chondrocyte Implantation), now commercially available. This innovation in knee cartilage defect treatment allows orthopedic surgeons to conduct the procedure through minimally invasive incisions using specialized instruments, offering a less invasive alternative to traditional methods. This approach is anticipated to improve patient recovery and reduce post-operative complications.

In July 2023, Avanos Medical Inc., a prominent US-based company specializing in pain management and chronic care solutions, successfully completed the acquisition of Diros Technology Inc. for a sum totaling $60 million. This strategic acquisition serves to bolster Avanos' standing as a frontrunner in the realm of radiofrequency (RF) technology, expanding its portfolio with a comprehensive range of cutting-edge pain treatment devices. Diros Technology Inc., based in Canada, specializes in crafting radiofrequency devices tailored to address joint disorders such as knee, cervical, and lumbar pain. This acquisition marks a significant step for Avanos, enriching its offerings and solidifying its position within the industry by integrating Diros' expertise and unique devices into its product line.

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chondroplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chondroplasty Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chondroplasty ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chondroplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
  • 2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
  • 3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
  • 4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses
  • Subsegments:
  • 1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation; Low-Frequency Ablation
  • 2) By Abrasion Chondroplasty: Mechanical Abrasion; Arthroscopic Abrasion
  • 3) By Patellar Chondroplasty: Open Patellar Chondroplasty; Arthroscopic Patellar Chondroplasty
  • 4) By Meniscal Repair: Suturing Techniques; Meniscal Allograft Transplantation
  • 5) By Tissue Removal: Arthroscopic Debridement; Open Debridement
  • 6) By Other Types: Microfracture Techniques; Osteochondral Autograft Transplantation
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Osiris Therapeutics Inc.; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Medtronic Public Limited Company; Stryker Corporation; Teva Pharmaceutical Industries Ltd.; B. Braun Melsungen AG; Zimmer Biomet Holdings Inc.; Smith & Nephew plc; Sigma-Aldrich Corporation; Arthrex Inc.; Bio-Rad Laboratories Inc; QIAGEN N.V.; CONMED Corporation; Promega Corporation; Organogenesis Holdings Inc.; Bioventus LLC; RTI Surgical Holdings Inc.; Vericel Corporation; Geistlich Pharma AG; Ocugen Inc.; MEDIPOST Co. Ltd.; GPC Medical Ltd.; Sklar Surgical Instruments; Isto Biologics; Nebula Inc.; NuOrtho Surgical Inc.; Medical Devices Business Services Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chondroplasty Market Characteristics

3. Chondroplasty Market Trends And Strategies

4. Chondroplasty Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chondroplasty Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Chondroplasty PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Chondroplasty Market Growth Rate Analysis
  • 5.4. Global Chondroplasty Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Chondroplasty Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Chondroplasty Total Addressable Market (TAM)

6. Chondroplasty Market Segmentation

  • 6.1. Global Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Chondroplasty
  • Abrasion Chondroplasty
  • Atellar Chondroplasty
  • Meniscal Repair
  • Tissue Removal
  • Other Types
  • 6.2. Global Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Knee
  • Shoulder
  • Hip
  • Other Anatomies
  • 6.3. Global Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Shavers
  • Radiofrequency Devices
  • Arthroscope
  • Other Equipments
  • 6.4. Global Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Academic Research
  • Other End Uses
  • 6.5. Global Chondroplasty Market, Sub-Segmentation Of Radiofrequency Ablation Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Frequency Ablation
  • Low-Frequency Ablation
  • 6.6. Global Chondroplasty Market, Sub-Segmentation Of Abrasion Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Abrasion
  • Arthroscopic Abrasion
  • 6.7. Global Chondroplasty Market, Sub-Segmentation Of Patellar Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Patellar Chondroplasty
  • Arthroscopic Patellar Chondroplasty
  • 6.8. Global Chondroplasty Market, Sub-Segmentation Of Meniscal Repair, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Suturing Techniques
  • Meniscal Allograft Transplantation
  • 6.9. Global Chondroplasty Market, Sub-Segmentation Of Tissue Removal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arthroscopic Debridement
  • Open Debridement
  • 6.10. Global Chondroplasty Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microfracture Techniques
  • Osteochondral Autograft Transplantation

7. Chondroplasty Market Regional And Country Analysis

  • 7.1. Global Chondroplasty Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Chondroplasty Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chondroplasty Market

  • 8.1. Asia-Pacific Chondroplasty Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chondroplasty Market

  • 9.1. China Chondroplasty Market Overview
  • 9.2. China Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chondroplasty Market

  • 10.1. India Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chondroplasty Market

  • 11.1. Japan Chondroplasty Market Overview
  • 11.2. Japan Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chondroplasty Market

  • 12.1. Australia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chondroplasty Market

  • 13.1. Indonesia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chondroplasty Market

  • 14.1. South Korea Chondroplasty Market Overview
  • 14.2. South Korea Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chondroplasty Market

  • 15.1. Western Europe Chondroplasty Market Overview
  • 15.2. Western Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chondroplasty Market

  • 16.1. UK Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chondroplasty Market

  • 17.1. Germany Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chondroplasty Market

  • 18.1. France Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chondroplasty Market

  • 19.1. Italy Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chondroplasty Market

  • 20.1. Spain Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chondroplasty Market

  • 21.1. Eastern Europe Chondroplasty Market Overview
  • 21.2. Eastern Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chondroplasty Market

  • 22.1. Russia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chondroplasty Market

  • 23.1. North America Chondroplasty Market Overview
  • 23.2. North America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chondroplasty Market

  • 24.1. USA Chondroplasty Market Overview
  • 24.2. USA Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chondroplasty Market

  • 25.1. Canada Chondroplasty Market Overview
  • 25.2. Canada Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chondroplasty Market

  • 26.1. South America Chondroplasty Market Overview
  • 26.2. South America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chondroplasty Market

  • 27.1. Brazil Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chondroplasty Market

  • 28.1. Middle East Chondroplasty Market Overview
  • 28.2. Middle East Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chondroplasty Market

  • 29.1. Africa Chondroplasty Market Overview
  • 29.2. Africa Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chondroplasty Market Competitive Landscape And Company Profiles

  • 30.1. Chondroplasty Market Competitive Landscape
  • 30.2. Chondroplasty Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Osiris Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Chondroplasty Market Other Major And Innovative Companies

  • 31.1. Medtronic Public Limited Company
  • 31.2. Stryker Corporation
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. B. Braun Melsungen AG
  • 31.5. Zimmer Biomet Holdings Inc.
  • 31.6. Smith & Nephew plc
  • 31.7. Sigma-Aldrich Corporation
  • 31.8. Arthrex Inc.
  • 31.9. Bio-Rad Laboratories Inc
  • 31.10. QIAGEN N.V.
  • 31.11. CONMED Corporation
  • 31.12. Promega Corporation
  • 31.13. Organogenesis Holdings Inc.
  • 31.14. Bioventus LLC
  • 31.15. RTI Surgical Holdings Inc.

32. Global Chondroplasty Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chondroplasty Market

34. Recent Developments In The Chondroplasty Market

35. Chondroplasty Market High Potential Countries, Segments and Strategies

  • 35.1 Chondroplasty Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Chondroplasty Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Chondroplasty Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer